Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00459862What this trial is testingPazopanib in Treating Patients With Malignant Pleural MesotheliomaWho this might be right forAdvanced Malignant MesotheliomaLocalized Malignant MesotheliomaRecurrent Malignant Mesothelioma National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT00003974What this trial is testingVaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II MesotheliomaWho this might be right forLung CancerMalignant Mesothelioma Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)UnknownNCT00030459What this trial is testingPalliative Therapy With or Without Chemotherapy in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma British Thoracic Society
Testing effectiveness (Phase 2)Study completedNCT00004254What this trial is testingRaltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically RemovedWho this might be right forMalignant Mesothelioma European Organisation for Research and Treatment of Cancer - EORTC 25
Testing effectiveness (Phase 2)Study completedNCT00309946What this trial is testingCediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryWho this might be right forAdvanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Study completedNCT00227630What this trial is testingPemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaWho this might be right forMalignant Mesothelioma European Organisation for Research and Treatment of Cancer - EORTC 59
Testing effectiveness (Phase 2)Study completedNCT00054002What this trial is testingSurgery and Photodynamic Therapy in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma Roswell Park Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT00004183What this trial is testingCapecitabine in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma Alliance for Clinical Trials in Oncology 27
Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Not applicableEnded earlyNCT00028782What this trial is testingEF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural CancerWho this might be right forAdvanced Malignant MesotheliomaLocalized Malignant MesotheliomaMalignant Ascites+2 more National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT01938443What this trial is testingA Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid TumorsWho this might be right forCancerNeoplasms GlaxoSmithKline 34